Sort
30,917 grants matching “tumor microenvironment”
The Epidemiology of Immune Responses in Colorectal Cancer
$651,654Stephen B Gruber · University Of Southern California · R01 · FY2016 · CA
Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer
$651,649Monica Morrow · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
AI enhanced lifetime-based mesoscopic in vivo imaging of tissue molecular heterogeneity
$651,479Xavier Intes · Rensselaer Polytechnic Institute · R01 · FY2025 · CA
Cancer Data Science (CDS)
$651,453Veerabhadran Baladandayuthapani · University Of Michigan At Ann Arbor · P30 · FY2024 · CA
Reprogramming of mature smooth muscle cells to vascular progenitor cells
$651,434Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2019 · HL
The role of Myeloid cells in pediatric-high grade gliomas
$651,334Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
$651,173Nirav Thosani · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
MS4A7 in tumor resistance to immunotherapy
$651,124Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$651,026Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2021 · CA
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2020 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2019 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2017 · AI
Mutagenic chain reaction-facilitated immunotherapy
$651,000Stephen M Hedrick · University Of California, San Diego · R01 · FY2016 · AI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
$650,996Elizabeth Marjorie Cespedes Feliciano · Kaiser Foundation Research Institute · R01 · FY2022 · CA
Investigating the Role of Emergent Oscillations of Hypoxia Inducible Factor-1 alpha Activity in Cancer Growth and Progression
$650,932Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt · R37 · FY2025 · CA
Angiogenesis and Tumor Growth
$650,913Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$650,815Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2017 · CA
Cancer Data Science (CDS)
$650,784Veerabhadran Baladandayuthapani · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Developing a novel combination immunotherapy for triple-negative breast cancer
$650,749Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2025 · CA
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$650,719Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy
$650,671Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
The Epidemiology of Immune Responses in Colorectal Cancer
$650,583Stephen B Gruber · University Of Southern California · R01 · FY2017 · CA
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$650,458Karl T Kelsey · Brown University · R01 · FY2022 · CA
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$650,406Nicholas C Denko · Ohio State University · R01 · FY2021 · CA
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$650,399Nabeel Bardeesy · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA